Page 17 - Read Online

Ciardullo et al. Metab Target Organ Damage 2024;4:30 https://dx.doi.org/10.20517/mtod.2024.39 Page 11 of

13. Ciardullo S, Oltolini A, Cannistraci R, Muraca E, Perseghin G. Sex-related association of nonalcoholic fatty liver disease and liver
fibrosis with body fat distribution in the general US population. Am J Clin Nutr 2022;115:1528-34. DOI PubMed
14. Ciardullo S, Monti T, Grassi G, Mancia G, Perseghin G. Blood pressure, glycemic status and advanced liver fibrosis assessed by
transient elastography in the general United States population. J Hypertens 2021;39:1621-7. DOI PubMed PMC
15. Ciardullo S, Perseghin G. Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes.
Metabolism 2021;121:154752. DOI PubMed
16. Younossi ZM, Stepanova M, Younossi Y, et al. Epidemiology of chronic liver diseases in the USA in the past three decades. Gut
2020;69:564-8. DOI PubMed
17. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-
analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73-84. DOI PubMed
18. Younossi ZM, Golabi P, Price JK, et al. The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
among patients with type 2 diabetes. Clin Gastroenterol Hepatol 2024;21:S1542-3565(24)00287. DOI PubMed
19. Younossi ZM, Golabi P, de Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a
systematic review and meta-analysis. J Hepatol 2019;71:793-801. DOI PubMed
20. Ciardullo S, Monti T, Perseghin G. Prevalence of liver steatosis and fibrosis detected by transient elastography in adolescents in the
2017-2018 national health and nutrition examination survey. Clin Gastroenterol Hepatol 2021;19:384-390.e1. DOI PubMed
21. Ciardullo S, Carbone M, Invernizzi P, Perseghin G. Impact of the new definition of metabolic dysfunction-associated fatty liver
disease on detection of significant liver fibrosis in US adolescents. Hepatol Commun 2022;6:2070-8. DOI PubMed PMC
22. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading
and staging the histological lesions. Am J Gastroenterol 1999;94:2467-74. DOI PubMed
23. Ekstedt M, Hagström H, Nasr P, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33
years of follow-up. Hepatology 2015;61:1547-54. DOI PubMed
24. Dulai PS, Singh S, Patel J, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and
meta-analysis. Hepatology 2017;65:1557-65. DOI PubMed PMC
25. Taylor RS, Taylor RJ, Bayliss S, et al. Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver
disease: a systematic review and meta-analysis. Gastroenterology 2020;158:1611-1625.e12. DOI PubMed
26. Bucci L, Garuti F, Lenzi B, et al; Italian Liver Cancer Group. The evolutionary scenario of hepatocellular carcinoma in Italy: an
update. Liver Int 2017;37:259-70. DOI PubMed
27. Piscaglia F, Svegliati-Baroni G, Barchetti A, et al; HCC-NAFLD Italian Study Group. Clinical patterns of hepatocellular carcinoma
in nonalcoholic fatty liver disease: a multicenter prospective study. Hepatology 2016;63:827-38. DOI PubMed
28. Perseghin G, Bonfanti R, Magni S, et al. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver
disease. Am J Physiol Endocrinol Metab 2006;291:E697-703. DOI PubMed
29. Valenti LVC, Moretti V. Implications of the evolving knowledge of the genetic architecture of MASLD. Nat Rev Gastroenterol
Hepatol 2024;21:5-6. DOI PubMed
30. Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet
2008;40:1461-5. DOI PubMed PMC
31. Palmer ND, Musani SK, Yerges-Armstrong LM, et al. Characterization of European ancestry nonalcoholic fatty liver disease-
associated variants in individuals of African and Hispanic descent. Hepatology 2013;58:966-75. DOI PubMed PMC
32. Krawczyk M, Rau M, Schattenberg JM, et al; NAFLD Clinical Study Group. Combined effects of the PNPLA3 rs738409, TM6SF2
rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study. J Lipid Res 2017;58:247-55.
DOI PubMed PMC
33. Liu YL, Reeves HL, Burt AD, et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty
liver disease. Nat Commun 2014;5:4309. DOI PubMed PMC
34. Riazi K, Swain MG, Congly SE, Kaplan GG, Shaheen AA. Race and ethnicity in non-alcoholic fatty liver disease (NAFLD): a
narrative review. Nutrients 2022;14:4556. DOI PubMed PMC
35. Rich NE, Oji S, Mufti AR, et al. Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in
the united states: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2018;16:198-210.e2. DOI PubMed PMC
36. Tovoli F, Stefanini B, Mandrioli D, et al. Exploring occupational toxicant exposures in patients with metabolic dysfunction-
associated steatotic liver disease: a prospective pilot study. Dig Liver Dis 2024;56:571-8. DOI PubMed
37. Polyzos SA, Kountouras J, Deretzi G, Zavos C, Mantzoros CS. The emerging role of endocrine disruptors in pathogenesis of insulin
resistance: a concept implicating nonalcoholic fatty liver disease. Curr Mol Med 2012;12:68-82. DOI PubMed
38. Cheng WC, Wong PY, Wu CD, Cheng PN, Lee PC, Li CY. Non-linear association between long-term air pollution exposure and risk
of metabolic dysfunction-associated steatotic liver disease. Environ Health Prev Med 2024;29:7. DOI PubMed PMC
39. Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol 2015;62:S47-64. DOI PubMed
40. Mantovani A, Petracca G, Beatrice G, Tilg H, Byrne CD, Targher G. Non-alcoholic fatty liver disease and risk of incident diabetes
mellitus: an updated meta-analysis of 501 022 adult individuals. Gut 2021;70:962-9. DOI PubMed
41. Mantovani A, Zaza G, Byrne CD, et al. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic
review and meta-analysis. Metabolism 2018;79:64-76. DOI PubMed
42. Ciardullo S, Ballabeni C, Trevisan R, Perseghin G. Liver fibrosis assessed by transient elastography is independently associated with